☰

Zhiyuan Hu, Ph.D. - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
fatty acid synthesis, adipogenesis
Tree Info Similar researchers PubMed Report error

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Liang N, Liu L, Li P, Xu Y, Hou Y, Peng J, Song Y, Bing Z, Wang Y, Wang Y, Jia Z, Yang X, Li D, Xu H, Yu Q, ... ... Hu Z, et al. Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles. Journal of Thoracic Disease. 12: 4262-4273. PMID 32944338 DOI: 10.21037/Jtd-20-1026A  0.322
2020 Wang Z, Sun M, Li W, Fan L, Zhou Y, Hu Z. A Novel CD133- and EpCAM-Targeted Liposome With Redox-Responsive Properties Capable of Synergistically Eliminating Liver Cancer Stem Cells. Frontiers in Chemistry. 8: 649. PMID 32850663 DOI: 10.3389/Fchem.2020.00649  0.302
2019 Wang Y, Wang Z, Qian Y, Fan L, Yue C, Jia F, Sun J, Hu Z, Wang W. Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics. Journal of Materials Chemistry. B. 7: 1056-1063. PMID 32254773 DOI: 10.1039/C8Tb03351J  0.304
2019 Shi F, Ma Y, Qian Y, Wang Y, Wang Z, Zhao M, Hu Z. A novel peptide probe for identification of PLS3-expressed cancer cells. Analytical Chemistry. PMID 31293151 DOI: 10.1021/Acs.Analchem.9B01061  0.321
2019 Wang Y, Jia F, Wang Z, Qian Y, Fan L, Gong H, Luo A, Sun J, Hu Z, Wang W. Boosting the Theranostic effect of Liposomal Probe towards Prominin-1 through Optimized 'Dual-site Targeting'. Analytical Chemistry. PMID 30920798 DOI: 10.1021/Acs.Analchem.9B00622  0.304
2019 Cong Y, Ji L, Gao YJ, Liu FH, Cheng DB, Hu Z, Qiao ZY, Wang H. Microenvironment Induced in Situ Self-Assembly of Polymer-Peptides Conjugates that Attack Solid Tumor Deeply. Angewandte Chemie (International Ed. in English). PMID 30695128 DOI: 10.1002/Anie.201900135  0.323
2018 Wang W, Hu Z. Targeting Peptide-Based Probes for Molecular Imaging and Diagnosis. Advanced Materials (Deerfield Beach, Fla.). e1804827. PMID 30537222 DOI: 10.1002/Adma.201804827  0.311
2018 Qian Y, Wang Y, Jia F, Wang Z, Yue C, Zhang W, Hu Z, Wang W. Tumor-microenvironment controlled nanomicelles with AIE property for boosting cancer therapy and apoptosis monitoring. Biomaterials. 188: 96-106. PMID 30339943 DOI: 10.1016/J.Biomaterials.2018.10.003  0.316
2018 Zhao M, Li H, Fan L, Ma Y, Gong H, Lai W, Fang Q, Hu Z. Quantitative proteomic analysis to the first commercialized liposomal paclitaxel nano-platform Lipusu revealed the molecular mechanism of the enhanced anti-tumor effect. Artificial Cells, Nanomedicine, and Biotechnology. 1-9. PMID 30231644 DOI: 10.1080/21691401.2018.1489822  0.308
2018 Wang W, Ma Z, Zhu S, Wan H, Yue J, Ma H, Ma R, Yang Q, Wang Z, Li Q, Qian Y, Yue C, Wang Y, Fan L, Zhong Y, ... ... Hu Z, et al. Molecular Cancer Imaging in the Second Near-Infrared Window Using a Renal-Excreted NIR-II Fluorophore-Peptide Probe. Advanced Materials (Deerfield Beach, Fla.). e1800106. PMID 29682821 DOI: 10.1002/Adma.201800106  0.317
2018 Qian Y, Wang W, Wang Z, Jia X, Han Q, Rostami I, Wang Y, Hu Z. pH Triggered Peptide Self-Assembly for Targeting Imaging and Therapy towards Angiogenesis with Enhanced Signals. Acs Applied Materials & Interfaces. PMID 29439558 DOI: 10.1021/Acsami.8B00583  0.327
2017 Qiao ZY, Zhao WJ, Gao YJ, Cong Y, Zhao L, Hu Z, Wang H. Reconfigurable Peptide Nanotherapeutics at Tumor Microenvironmental pH. Acs Applied Materials & Interfaces. PMID 28828864 DOI: 10.1021/Acsami.7B09033  0.322
2017 Zhu L, Zhao Z, Cheng P, He Z, Cheng Z, Peng J, Wang H, Wang C, Yang Y, Hu Z. Antibody-Mimetic Peptoid Nanosheet for Label-Free Serum-Based Diagnosis of Alzheimer's Disease. Advanced Materials (Deerfield Beach, Fla.). PMID 28605073 DOI: 10.1002/Adma.201700057  0.507
2017 Yang X, Wang Z, Xiang Z, Li D, Hu Z, Cui W, Geng L, Fang Q. Peptide probes derived from pertuzumab by molecular dynamics modeling for HER2 positive tumor imaging. Plos Computational Biology. 13: e1005441. PMID 28406988 DOI: 10.1371/Journal.Pcbi.1005441  0.324
2017 Jia X, Han Q, Wang Z, Qian Y, Jia Y, Wang W, Hu Z. Targeting peptide functionalized liposomes towards aminopeptidase N for precise tumor diagnosis and therapy. Biomaterials Science. PMID 28138675 DOI: 10.1039/C6Bm00898D  0.331
2016 Xiang Z, Yang X, Xu J, Lai W, Wang Z, Hu Z, Tian J, Geng L, Fang Q. Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide. Biomaterials. 115: 53-64. PMID 27888699 DOI: 10.1016/J.Biomaterials.2016.11.022  0.339
2016 Han Q, Wang W, Jia X, Qian Y, Li Q, Wang Z, Zhang W, Yang S, Jia Y, Hu Z. Switchable Liposomes: Targeting Peptides Functionalized and pH-Triggered Cytoplasmic Delivery. Acs Applied Materials & Interfaces. PMID 27391018 DOI: 10.1021/Acsami.6B05678  0.319
2016 Geng L, Wang Z, Jia X, Han Q, Xiang Z, Li D, Yang X, Zhang D, Bu X, Wang W, Hu Z, Fang Q. HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery. Theranostics. 6: 1261-73. PMID 27279916 DOI: 10.7150/Thno.14302  0.336
2016 Jia X, Wang W, Han Q, Wang Z, Jia Y, Hu Z. Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery. Acs Medicinal Chemistry Letters. 7: 429-34. PMID 27096054 DOI: 10.1021/Acsmedchemlett.6B00028  0.305
2016 Qian Y, Wang W, Wang Z, Han Q, Jia X, Yang S, Hu Z. Switchable probes: pH-triggered and VEGFR2 targeted peptides screening through imprinting microarray. Chemical Communications (Cambridge, England). PMID 27035754 DOI: 10.1039/C6Cc01302C  0.307
2016 Rostami I, Zhao Z, Wang Z, Zhang W, Zhong Y, Zeng Q, Jia X, Hu Z. Peptide-conjugated PEGylated PAMAM as a highly affinitive nanocarrier towards HER2-overexpressing cancer cells Rsc Advances. 6: 107337-107343. DOI: 10.1039/C6Ra19552K  0.344
2015 Wang W, Wang Z, Bu X, Li R, Zhou M, Hu Z. Tumor Diagnosis: Discovering of Tumor-targeting Peptides using Bi-functional Microarray (Adv. Healthcare Mater. 18/2015). Advanced Healthcare Materials. 4: 2738. PMID 26727343 DOI: 10.1002/Adhm.201570102  0.319
2015 Wang W, Wang Z, Bu X, Li R, Zhou M, Hu Z. Discovering of Tumor-targeting Peptides using Bi-functional Microarray. Advanced Healthcare Materials. PMID 26548577 DOI: 10.1002/Adhm.201500724  0.312
2015 Geng L, Wang Z, Yang X, Li D, Lian W, Xiang Z, Wang W, Bu X, Lai W, Hu Z, Fang Q. Structure-based Design of Peptides with High Affinity and Specificity to HER2 Positive Tumors. Theranostics. 5: 1154-65. PMID 26284145 DOI: 10.7150/Thno.12398  0.325
2015 Wang Z, Wang W, Bu X, Wei Z, Geng L, Wu Y, Dong C, Li L, Zhang D, Yang S, Wang F, Lausted C, Hood L, Hu Z. Microarray based Screening of Peptide Nano Probes for HER2 Positive Tumor. Analytical Chemistry. PMID 26218790 DOI: 10.1021/Acs.Analchem.5B01588  0.328
2015 Wang W, Zhang D, Wei Z, Wang Z, Bu X, Yang S, Fang Q, Hu Z. Label-free detection microarray for novel peptide ligands screening base on MS-SPRi combination. Talanta. 134: 705-11. PMID 25618725 DOI: 10.1016/J.Talanta.2014.12.012  0.313
2014 Wang W, Wei Z, Zhang D, Ma H, Wang Z, Bu X, Li M, Geng L, Lausted C, Hood L, Fang Q, Wang H, Hu Z. Rapid screening of peptide probes through in situ single-bead sequencing microarray. Analytical Chemistry. 86: 11854-9. PMID 25370073 DOI: 10.1021/Ac503454Z  0.314
2014 Wang W, Li M, Wei Z, Wang Z, Bu X, Lai W, Yang S, Gong H, Zheng H, Wang Y, Liu Y, Li Q, Fang Q, Hu Z. Bimodal imprint chips for peptide screening: integration of high-throughput sequencing by MS and affinity analyses by surface plasmon resonance imaging. Analytical Chemistry. 86: 3703-7. PMID 24641070 DOI: 10.1021/Ac500465E  0.304
2007 Chakravarthy MV, Zhu Y, López M, Yin L, Wozniak DF, Coleman T, Hu Z, Wolfgang M, Vidal-Puig A, Lane MD, Semenkovich CF. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. The Journal of Clinical Investigation. 117: 2539-52. PMID 17694178 DOI: 10.1172/Jci31183  0.499
2005 Lane MD, Hu Z, Cha SH, Dai Y, Wolfgang M, Sidhaye A. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure. Biochemical Society Transactions. 33: 1063-7. PMID 16246046 DOI: 10.1042/Bst20051063  0.496
2005 Hu Z, Dai Y, Prentki M, Chohnan S, Lane MD. A role for hypothalamic malonyl-CoA in the control of food intake. The Journal of Biological Chemistry. 280: 39681-3. PMID 16219771 DOI: 10.1074/Jbc.C500398200  0.497
2005 Cha SH, Hu Z, Chohnan S, Lane MD. Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 102: 14557-62. PMID 16203972 DOI: 10.1073/Pnas.0507300102  0.475
2005 Dowell P, Hu Z, Lane MD. Monitoring energy balance: metabolites of fatty acid synthesis as hypothalamic sensors. Annual Review of Biochemistry. 74: 515-34. PMID 15952896 DOI: 10.1146/Annurev.Biochem.73.011303.074027  0.474
2005 Hu Z, Cha SH, van Haasteren G, Wang J, Lane MD. Effect of centrally administered C75, a fatty acid synthase inhibitor, on ghrelin secretion and its downstream effects. Proceedings of the National Academy of Sciences of the United States of America. 102: 3972-7. PMID 15728730 DOI: 10.1073/Pnas.0500619102  0.488
2004 Cha SH, Hu Z, Lane MD. Long-term effects of a fatty acid synthase inhibitor on obese mice: food intake, hypothalamic neuropeptides, and UCP3. Biochemical and Biophysical Research Communications. 317: 301-8. PMID 15063757 DOI: 10.1016/J.Bbrc.2004.03.026  0.485
2003 Hu Z, Cha SH, Chohnan S, Lane MD. Hypothalamic malonyl-CoA as a mediator of feeding behavior. Proceedings of the National Academy of Sciences of the United States of America. 100: 12624-9. PMID 14532332 DOI: 10.1073/Pnas.1834402100  0.49
Show low-probability matches.